Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a low-dose, oral COVID antiviral drug that can be administered at home.
Deep learning dreams up new protein structures - Innovations Report innovations-report.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from innovations-report.com Daily Mail and Mail on Sunday newspapers.